This inventor holds 2 USPTO granted patents and 1 published patent application and 3 EPO patents. Top assignee: Janssen Pharmaceutica Nv. Active years: 2016-2021.
Location History:
- Radnor, PA (US) (2016)
- Norristown, PA (US) (2021)
Company Filing History:
Years Active: 2016-2021
Title: Weimin Li: Innovator in Cancer Treatment
Introduction
Weimin Li is a notable inventor based in Norristown, PA (US), recognized for his contributions to cancer treatment innovations. With a total of 2 patents, he has made significant strides in the field of oncology, particularly in the development of biological markers that aid in patient treatment.
Latest Patents
Li's latest patents include groundbreaking methods for predicting patient survival and treatment responses. One patent focuses on biological markers for identifying patients suitable for treatment with abiraterone acetate. This invention provides methods to predict the likelihood of survival following treatment with abiraterone acetate and prednisone in patients with castration-resistant prostate cancer (CRPC). Another patent presents methods for predicting responses to cancer treatment by determining CD68 levels or PSMB1 (P11A) polymorphism in biological samples, along with the presence or quantity of a second biomarker in patients. This invention also includes kits and methods for treating cancer.
Career Highlights
Weimin Li is currently associated with Janssen Pharmaceutica NV, where he continues to work on innovative solutions in cancer treatment. His research and inventions have the potential to significantly impact patient care and treatment outcomes.
Collaborations
Li collaborates with esteemed colleagues, including Deborah Sokol Ricci and Michael Gormley, to advance research in the field of oncology. Their combined expertise fosters an environment of innovation and discovery.
Conclusion
Weimin Li's contributions to cancer treatment through his patents and collaborations highlight his commitment to improving patient outcomes. His work exemplifies the importance of innovation in the medical field, particularly in the fight against cancer.